MARKERS AND METHODS RELATING TO THE ASSESSMENT OF ALZHEIMER'S DISEASE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20110082187A1
SERIAL NO

12878266

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Use of clusterin as a biomarker of Alzheimer's disease (AD), particularly methods and compositions for detection of clusterin in a biological sample and assessment of in vivo pathology, disease severity and rate of clinical progression in a subject having or suspected of having AD.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KING'S COLLEGE LONDONLONDON LONDON LONDON

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
CAMPBELL, JAMES COBHAM, GB 78 436
LOVESTONE, SIMON LONDON, GB 7 29
THAMBISETTY, MADHAV SILVER SPRING, US 2 9

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation